Incontinence is a widespread problem in all health care setting. One of the main complications of incontinence is inflammation of the skin in the genital and anal region, also known as incontinence-associated dermatitis (IAD). IAD is a known risk factor of pressure ulcer development. Prevalence figures of IAD vary between 5.6% and 50%. The primary aim of this study is to compare the effectiveness of a 3-in-1 genital wipe versus standard care (traditional water and soap) for the prevention of IAD. The second aim is to perform a health economic evaluation of the 3-in-1 genital wipe versus standard care, and third to compare the cost of a 2-in-1 total body wash wipe versus standard care for total body wash. Other outcomes are the comfort and tolerance of both the nurses and participants. In this Randomized Controlled Trial, performed in 13 long-term care settings, the participants will undergo a 30 day study period. In the experimental intervention, the participants will be washed with body wash wipes and genital wipes. In the control group, the subjects will receive traditional care. IAD as well as Pressure Ulcer prevalence will be monitored. Subjective and objective time measurements will be performed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
385
Woonzorgcentrum Sint-Jozef
Bruges, Belgium
Woonzorgcentrum Ceder aan de Leie
Harelbeke, Belgium
Woonzorgcentrum Heilig Hart
Kortrijk, Belgium
Woonzorgcentrum Sint-Jozef
Kortrijk, Belgium
Woonzorgcentrum De Samaritaan
Nukerke, Belgium
Woonzorgcentrum de Boarebreker
Ostend, Belgium
Woonzorgcentrum De Kroon
Sint-Gillis-Waas, Belgium
Woonzorgcentrum Deken Darras
Tielt, Belgium
Woonzorgcentrum Onze Lieve Vrouw van Lourdes
Wakken, Belgium
Woonzorgcentrum Duneroze
Wenduine, Belgium
...and 1 more locations
Incidence and category of Incontinence-Associated Dermatitis
Time frame: within the first 30 days after start of the study
Incidence and category of Pressure Ulcers
Time frame: within the first 30 days after start of the study
Comfort and tolerance of the participant
Questions on comfort and tolerance of the washing method will be assessed by the caregiver. At baseline (day 0) these questions will assess the traditional care. In the middle (day 14) and at the end of the study (day 30) the comfort and tolerance of washing with wash wipes will be assessed in the experimental group. In the control group, comfort and tolerance of traditional care will be assessed three times.
Time frame: On baseline, at day 14 and at day 30 (the end of the study)
Comfort and preferences of the caregiver
Questions on comfort and preferences of the washing method will be assessed. At baseline (day 0) these questions will assess the traditional care. In the middle (day 14) and at the end of the study (day 30) the comfort and preferences of washing with wash wipes will be assessed.
Time frame: On baseline, at day 14 and at day 30 (the end of the study)
adverse effects of the intervention
Adverse effects such as skin irritation, rash, itching, treatment related pain, skin dryness related to the interventions under study will be monitored.
Time frame: within the first 30 days after start of the study
Cost of the experiment (use of wash wipes) versus the standard care
* recording the daily consumption of towels, wash wipes,... * subjective time analyses of the washing methods: Estimated time registration by the caregiver * objective time analyses of the washing methods: time registration using a chronometer, conducted by researcher * retrieval of overhead costs related to traditional hygienic care: washing equipment purchase costs, general water and electricity: given per institution
Time frame: For the duration of the study (30 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.